Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

368.03
-7.9100-2.10%
Post-market: 368.570.5391+0.15%16:39 EDT
Volume:265.00K
Turnover:97.48M
Market Cap:10.25B
PE:-28.61
High:375.94
Open:375.94
Low:360.19
Close:375.94
52wk High:392.70
52wk Low:37.19
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.61
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:7.64
PE(LYR):-27.31

Loading ...

Praxis Precision Medicine Q1 EPS $(3.20) Beats $(3.50) Estimate

Benzinga Earnings
·
May 07

BRIEF-Praxis Precision Q1 EPS USD -3.2

Reuters
·
May 07

Praxis Precision Q1 Operating Income USD -105.86 Million

THOMSON REUTERS
·
May 07

Praxis Precision Q1 Net Income USD -92.561 Million

THOMSON REUTERS
·
May 07

Press Release: Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 07

Praxis Precision Medicines grants 5,420 RSUs to 21 new employees under inducement plan

Reuters
·
May 06

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 06

Praxis Precision Medicines Inc expected to post a loss of $3.57 a share - Earnings Preview

Reuters
·
May 05

Praxis Precision Medicines updates financial calendar for first-quarter results and investor conference

Reuters
·
May 05

Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference

GlobeNewswire
·
May 05

How Investors May Respond To Praxis (PRAX) Securing Dual FDA Reviews For Key Neurology Drug Candidates

Simply Wall St.
·
Apr 29

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Moderna (MRNA)

TIPRANKS
·
Apr 26

Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Apr 25

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Roche Holding (OtherRHHBY), Praxis Precision Medicines (PRAX) and SAB Biotherapeutics (SABS)

TIPRANKS
·
Apr 24

Praxis Precision Medicines (PRAX) Gets a Buy from LifeSci Capital

TIPRANKS
·
Apr 22

Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), Spyre Therapeutics (SYRE)

TIPRANKS
·
Apr 18

Praxis Ulixacaltamide Milestone Reframes Essential Tremor Opportunity And Valuation

Simply Wall St.
·
Apr 18

Deutsche Bank Adjusts Praxis Precision Medicines Price Target to $437 From $412, Maintains Buy Rating

MT Newswires Live
·
Apr 15

Praxis Precision NDA for Ulixacaltamide in Essential Tremor

TIPRANKS
·
Apr 15

Praxis Precision Med Price Target Maintained With a $510.00/Share by Needham

Dow Jones
·
Apr 14